NCT01146171 2012-02-07Japanese Phase 1 Study of BMS-844203 (CT322)Bristol-Myers SquibbPhase 1 Withdrawn
NCT00374179 2009-02-24CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's LymphomaAdnexus, A Bristol-Myers Squibb R&D CompanyPhase 1 Completed40 enrolled